SE9804003D0 - A method of producing drug particles - Google Patents

A method of producing drug particles

Info

Publication number
SE9804003D0
SE9804003D0 SE9804003A SE9804003A SE9804003D0 SE 9804003 D0 SE9804003 D0 SE 9804003D0 SE 9804003 A SE9804003 A SE 9804003A SE 9804003 A SE9804003 A SE 9804003A SE 9804003 D0 SE9804003 D0 SE 9804003D0
Authority
SE
Sweden
Prior art keywords
drug particles
producing drug
producing
susceptible
degradation
Prior art date
Application number
SE9804003A
Other languages
English (en)
Swedish (sv)
Inventor
Catherine Boissier
Anne Mari Juppo
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9804003A priority Critical patent/SE9804003D0/xx
Publication of SE9804003D0 publication Critical patent/SE9804003D0/xx
Priority to JP2000583496A priority patent/JP4612191B2/ja
Priority to EP99963729A priority patent/EP1133283B1/fr
Priority to DE69920945T priority patent/DE69920945T2/de
Priority to ES99963729T priority patent/ES2228148T3/es
Priority to CA002349711A priority patent/CA2349711C/fr
Priority to US09/486,688 priority patent/US6596315B1/en
Priority to AU20102/00A priority patent/AU754385B2/en
Priority to PCT/SE1999/002152 priority patent/WO2000030612A1/fr
Priority to AT99963729T priority patent/ATE278390T1/de
Priority to DK99963729T priority patent/DK1133283T3/da
Priority to PT99963729T priority patent/PT1133283E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D11/00—Solvent extraction
    • B01D11/04—Solvent extraction of solutions which are liquid
    • B01D11/0403—Solvent extraction of solutions which are liquid with a supercritical fluid
    • B01D11/0411—Solvent extraction of solutions which are liquid with a supercritical fluid the supercritical fluid acting as solvent for the solvent and as anti-solvent for the solute, e.g. formation of particles from solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE9804003A 1998-11-23 1998-11-23 A method of producing drug particles SE9804003D0 (sv)

Priority Applications (12)

Application Number Priority Date Filing Date Title
SE9804003A SE9804003D0 (sv) 1998-11-23 1998-11-23 A method of producing drug particles
PT99963729T PT1133283E (pt) 1998-11-23 1999-11-22 Um metodo de producao de particulas de farmaco
ES99963729T ES2228148T3 (es) 1998-11-23 1999-11-22 Metodo de produccion de particulas de farmacos.
EP99963729A EP1133283B1 (fr) 1998-11-23 1999-11-22 Procede de production de particules medicamenteuses
DE69920945T DE69920945T2 (de) 1998-11-23 1999-11-22 Verfahren zur herstellung von arzneistoffpartikeln
JP2000583496A JP4612191B2 (ja) 1998-11-23 1999-11-22 薬物粒子の製造方法
CA002349711A CA2349711C (fr) 1998-11-23 1999-11-22 Procede de production de particules medicamenteuses
US09/486,688 US6596315B1 (en) 1998-11-23 1999-11-22 Method of producing drug particles
AU20102/00A AU754385B2 (en) 1998-11-23 1999-11-22 A method of producing drug particles
PCT/SE1999/002152 WO2000030612A1 (fr) 1998-11-23 1999-11-22 Procede de production de particules medicamenteuses
AT99963729T ATE278390T1 (de) 1998-11-23 1999-11-22 Verfahren zur herstellung von arzneistoffpartikeln
DK99963729T DK1133283T3 (da) 1998-11-23 1999-11-22 Fremgangsmåde til fremstilling af lægemiddelpartikler

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9804003A SE9804003D0 (sv) 1998-11-23 1998-11-23 A method of producing drug particles

Publications (1)

Publication Number Publication Date
SE9804003D0 true SE9804003D0 (sv) 1998-11-23

Family

ID=20413380

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9804003A SE9804003D0 (sv) 1998-11-23 1998-11-23 A method of producing drug particles

Country Status (12)

Country Link
US (1) US6596315B1 (fr)
EP (1) EP1133283B1 (fr)
JP (1) JP4612191B2 (fr)
AT (1) ATE278390T1 (fr)
AU (1) AU754385B2 (fr)
CA (1) CA2349711C (fr)
DE (1) DE69920945T2 (fr)
DK (1) DK1133283T3 (fr)
ES (1) ES2228148T3 (fr)
PT (1) PT1133283E (fr)
SE (1) SE9804003D0 (fr)
WO (1) WO2000030612A1 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
CA2290893C (fr) 1999-11-16 2007-05-01 Bernard Charles Sherman Omeprazole de magnesium
GB0016040D0 (en) * 2000-06-29 2000-08-23 Glaxo Group Ltd Novel process for preparing crystalline particles
GB0027357D0 (en) 2000-11-09 2000-12-27 Bradford Particle Design Plc Particle formation methods and their products
AU2002221320B2 (en) * 2000-12-08 2006-06-15 The University Of Sydney Synthesis of small particles
AUPR197000A0 (en) * 2000-12-08 2001-01-11 Unisearch Limited Synthesis of small particles
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
CA2478475A1 (fr) 2002-02-25 2003-09-04 Phasex Corporation Procede de sechage de materiaux a base d'eau
US7862751B2 (en) 2002-04-15 2011-01-04 Map Pharmaceuticals, Inc. Formulation of fine particles using liquefield or dense gases
US7612098B2 (en) 2002-08-30 2009-11-03 Dr. Reddy's Laboratories Limited Amorphous hydrous esomeprazole magnesium
WO2004046134A2 (fr) * 2002-11-18 2004-06-03 Dr. Reddy's Laboratories Limited Composes d'esomeprazole cristallins et procede permettant de preparer ces composes
US7354601B2 (en) 2003-05-08 2008-04-08 Walker Stephen E Particulate materials
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
WO2007009164A1 (fr) 2005-07-15 2007-01-25 Eiffel Technologies Limited Procede de formation de particules
WO2007138606A2 (fr) * 2006-06-01 2007-12-06 Dexcel Pharma Technologies Ltd. Formulation pharmaceutique comprenant des unités multiples
ES2538082T3 (es) 2007-02-11 2015-06-17 Map Pharmaceuticals Inc Método de administración terapéutica de DHE para permitir el rápido alivio de migraña mientras que se minimiza el perfil de efectos secundarios
MX350838B (es) 2011-02-11 2017-09-18 Grain Proc Corporation * Composicion de sal.
EP3288556A4 (fr) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Compositions à désintégration par voie orale
WO2017145146A1 (fr) 2016-02-25 2017-08-31 Dexcel Pharma Technologies Ltd. Compositions comprenant des inhibiteurs de la pompe à protons
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3744329A1 (de) 1987-12-28 1989-07-06 Schwarz Pharma Gmbh Verfahren zur herstellung einer mindestens einen wirkstoff und einen traeger umfassenden zubereitung
HU209603B (en) * 1988-10-05 1994-09-28 Upjohn Co Process for production of solid powders in finalydivided microcristallin form
AU5171293A (en) * 1992-10-14 1994-05-09 Regents Of The University Of Colorado, The Ion-pairing of drugs for improved efficacy and delivery
GB9413202D0 (en) 1994-06-30 1994-08-24 Univ Bradford Method and apparatus for the formation of particles
US6932962B1 (en) * 1994-12-22 2005-08-23 Astrazeneca Ab Aerosol drug formulations containing hydrofluoroalkanes and alkyl saccharides
AU709262B2 (en) 1995-10-17 1999-08-26 Board Of Regents, The University Of Texas System Insoluble drug delivery
SE510666C2 (sv) * 1996-12-20 1999-06-14 Astra Ab Nya Kristallmodifikationer

Also Published As

Publication number Publication date
ES2228148T3 (es) 2005-04-01
JP4612191B2 (ja) 2011-01-12
CA2349711A1 (fr) 2000-06-02
AU2010200A (en) 2000-06-13
US6596315B1 (en) 2003-07-22
WO2000030612A1 (fr) 2000-06-02
DE69920945D1 (de) 2004-11-11
CA2349711C (fr) 2008-07-15
EP1133283B1 (fr) 2004-10-06
PT1133283E (pt) 2005-01-31
DK1133283T3 (da) 2005-01-24
AU754385B2 (en) 2002-11-14
JP2002530317A (ja) 2002-09-17
EP1133283A1 (fr) 2001-09-19
ATE278390T1 (de) 2004-10-15
DE69920945T2 (de) 2005-08-25

Similar Documents

Publication Publication Date Title
SE9804003D0 (sv) A method of producing drug particles
ATE364620T1 (de) Amphotere sterole und deren verwendung
MXPA03010201A (es) Derivados de 2-piridin-ciclohexan-1,4-diamina sustituidos.
IS5884A (is) Aðferð til framleiðslu á hreinu sítalóprami
DK0828717T3 (da) Fremgangsmåde til fremstilling af 3-haloalkyl-1H-pyrazol
DK0859766T3 (da) Chirale methylphenyloxazolidinoner
DK1083903T3 (da) Brobundne indenopyrrolocarbazoler
ATE202483T1 (de) Immuntolerante prothrombinkomplex-präparation
BRPI0112375B8 (pt) aplidinas como derivados antitumorais
NO990596D0 (no) FremgangsmÕte for drift av en olje- og gassproduksjonsbr°nn aktivisert av et pumpesystem
TR199800608A3 (tr) Propanolamin türevleri, bunlarin üretim usulü.
DE1169296T1 (de) Niedrigdruckreaktor zur herstellung von aminen
ATE237568T1 (de) Neue substanzbibliothek und damit hergestellte supramolekulare komplexe
BR0114380A (pt) Derivados-1-aminobutan-3-ol-substituìdos
MXPA04004090A (es) Compuestos substituidos de 1h-quinolin-2-ona.
MY127328A (en) 5-amino-1-pentene-3-ol substituted derivatives
ATE466847T1 (de) Verfahren zur herstellung von 14-beta- hydroxybaccatin-iii-1,14-carbonat
ATE537160T1 (de) Verfahren zur herstellung von 14beta- hydroxybaccatin-iii-1,14-carbonat
ATE267206T1 (de) 5-imino-13-deoxy-antracyclin-derivate, ihre verwendung sowie verfahren zu deren herstellung
MXPA04001852A (es) Uso de sistemas indan-1-ol c2-sustituidas para la produccion de medicamentos para la profilaxis o tratamiento de obesidad.
TR199801514A3 (tr) N-Piruvil-L-Prolin üretimi için yöntem.
MXPA04001846A (es) Indan-1-onas c2-substituidas y sus derivados, metodos para su produccion y su uso como medicamentos.
ECSP972189A (es) Nuevas triazolopurinas, procedimientos para su preparacion y su empleo como medicamentos
IT1293008B1 (it) Metodo per la realizzazione di assiemi ornamentali, particolarmente per il settore orafo, nonche' assiemi ottenuti con tale metodo.
IT1306870B1 (it) Impianto di scenografia per la proiezione di immagini ad effettotridimensionale simulato.